Radiation Therapy to Treat Musculoskeletal Tumors
Image Guided Radiotherapy for the Treatment of Musculoskeletal Tumors: A Phase II Prospective Evaluation of Radiation-related Treatment Effects
Sponsor: Lance Armstrong Foundation
Listed as NCT00186992, this PHASE2 trial focuses on Musculoskeletal Tumors and Rhabdomyosarcoma and remains ongoing. Sponsored by Lance Armstrong Foundation, it has been updated 20 times since 2003, reflecting substantial change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
20 versions recorded-
Mar 2026 — Present [monthly]
Active Not Recruiting PHASE2
-
Apr 2025 — Mar 2026 [monthly]
Active Not Recruiting PHASE2
-
Dec 2024 — Apr 2025 [monthly]
Active Not Recruiting PHASE2
-
Sep 2024 — Dec 2024 [monthly]
Active Not Recruiting PHASE2
-
Jul 2024 — Sep 2024 [monthly]
Active Not Recruiting PHASE2
▶ Show 15 earlier versions
-
May 2024 — Jul 2024 [monthly]
Active Not Recruiting PHASE2
-
May 2023 — May 2024 [monthly]
Active Not Recruiting PHASE2
-
May 2022 — May 2023 [monthly]
Active Not Recruiting PHASE2
-
May 2021 — May 2022 [monthly]
Active Not Recruiting PHASE2
-
Jan 2021 — May 2021 [monthly]
Active Not Recruiting PHASE2
-
Dec 2020 — Jan 2021 [monthly]
Active Not Recruiting PHASE2
-
Feb 2020 — Dec 2020 [monthly]
Active Not Recruiting PHASE2
-
Dec 2019 — Feb 2020 [monthly]
Active Not Recruiting PHASE2
-
Dec 2018 — Dec 2019 [monthly]
Active Not Recruiting PHASE2
-
Jun 2018 — Dec 2018 [monthly]
Active Not Recruiting PHASE2
-
Dec 2017 — Jun 2018 [monthly]
Active Not Recruiting PHASE2
-
Oct 2017 — Dec 2017 [monthly]
Active Not Recruiting PHASE2
-
May 2017 — Oct 2017 [monthly]
Active Not Recruiting PHASE2
-
Feb 2017 — May 2017 [monthly]
Active Not Recruiting PHASE2
-
Jan 2017 — Feb 2017 [monthly]
Active Not Recruiting PHASE2
First recorded
Jan 2003
Trial started
Per CT.gov start date — pre-dates our first snapshot
Eligibility Summary
No eligibility information available.
Contact Information
- Lance Armstrong Foundation
- St. Jude Children's Research Hospital
For direct contact, visit the study record on ClinicalTrials.gov .